Relmada Therapeutics RLMD
NASDAQ RLMD
$3.77 +0.04 (+1.07%)
At close: Sep 30, 2026 · 4:00 PM EDT

Relmada Therapeutics (RLMD) Operating Margin (2012 - 2013)

Updated

Relmada Therapeutics (RLMD) posted Operating Margin of -877.66% for FY2013, down 725.89 percentage points from -151.77% in FY2012.

Analysis

Relmada Therapeutics (RLMD) Operating Margin (2012 - 2013) Analysis & Trends

  • Business Quant data shows RLMD's Operating Margin at -151.77% in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 28.21%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 37.86%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -3.52%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 32.97%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 20.57%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 34.95%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 37.40%
10 Relmada Therapeutics 397.88 Mn 397.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2013 -776.97%
May 31, 2013 -3,073.34%
Feb 28, 2013 -176.73%
Nov 30, 2012 -419.73%
Aug 31, 2012 -569.57%
May 31, 2012 -620.25%
API Access

Relmada Therapeutics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=RLMD&period=max&api_key=YOUR_API_KEY